More articles from Review

  • Statins may increase diabetes, but benefit still outweighs risk
    Byron J. Hoogwerf, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 53-62; DOI: https://doi.org/10.3949/ccjm.90a.22069

    The weight of the evidence suggests that statin use is associated with an increased risk of new-onset diabetes mellitus, but the magnitude of the effect has varied across studies.

  • Bone turnover markers to monitor oral bisphosphonate therapy
    Nikita Ashcherkin, MD, Archna A. Patel, MD, MPH, Alicia Algeciras-Schimnich, PhD and Krupa B. Doshi, MD, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 26-31; DOI: https://doi.org/10.3949/ccjm.90a.22002

    Rapid changes in levels of bone turnover markers can be useful in monitoring the effectiveness of therapy and improving adherence to therapy.

  • Update in cutaneous manifestations of COVID-19: Special populations
    Update in cutaneous manifestations of COVID-19: Special populations
    Samantha Polly, MD, Inga M. Muser, MD and Anthony P. Fernandez, MD, PhD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 43-52; DOI: https://doi.org/10.3949/ccjm.90a.22013

    Recognition of skin reactions and their implications is beneficial to clinicians in shaping patient counseling and anticipatory guidance. An illustrated guide.

  • Is your patient at risk for NAFLD?
    Patress Ann Persons, MD, FACP, Sophie Bersoux, MD, MPH, FACP and Mary Helen Whited, MD, FACP
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 719-727; DOI: https://doi.org/10.3949/ccjm.89a.22005

    The authors review identifying individuals at risk, treatment options founded on lifestyle modification, and when to consider referring patients to a hepatologist.

  • On the horizon: Extracorporeal carbon dioxide removal
    On the horizon: Extracorporeal carbon dioxide removal
    Justin Hanks, DO, Steven Fox, MD, Omar Mehkri, MD, Laura W. Lund, PhD, Tracey Dill, RRT, Abhijit Duggal, MD, MPH, MSc and Sudhir Krishnan, MD
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 712-718; DOI: https://doi.org/10.3949/ccjm.89a.21084

    Extracorporeal carbon dioxide removal to treat hypercapnic respiratory failure has been studied in acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and other conditions.

  • Benign paroxysmal positional vertigo: Effective diagnosis and treatment
    Benign paroxysmal positional vertigo: Effective diagnosis and treatment
    Shayna R. Cole, AuD, CCC-A and Julie A. Honaker, PhD, CCC-A
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 653-662; DOI: https://doi.org/10.3949/ccjm.89a.21057

    The authors review how to differentiate this balance disorder from others, and how best to treat it with position-changing maneuvers.

  • Reducing the risk of breast cancer
    Holly J. Pederson, MD, Zahraa Al-Hilli, MD and Allison W. Kurian, MD
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 643-652; DOI: https://doi.org/10.3949/ccjm.89a.21113

    Breast cancer remains the most common malignancy in US women. Reducing this burden involves identification of high-risk individuals and personalized risk management.

  • Geriatric update 2022: Preventing Alzheimer disease and more
    Melissa Morgan-Gouveia, MD, Kathleen Drago, MD, FACP, Patricia Harris, MD, MS and Meera Sheffrin, MD, MAS
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 617-624; DOI: https://doi.org/10.3949/ccjm.89a.21094

    Key topics include Alzheimer dementia, effects of frailty and social isolation, COVID-19 risks in patients with dementia, hospital-at-home programs, deprescribing antihypertensive drugs, bisphosphonate-related fractures, and cannabis use.

  • Primary and secondary prevention of atherosclerotic cardiovascular disease: A case-based approach
    Essa H. Hariri, MD, MS, Mazen M. Al Hammoud, BS, Steven E. Nissen, MD and Donald F. Hammer, MD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 513-522; DOI: https://doi.org/10.3949/ccjm.89a.21103

    The authors present commonly encountered clinical scenarios that pose challenges in decision-making in primary and secondary prevention.

  • Cirrhotic coagulopathy: A rebalanced hemostasis
    Cirrhotic coagulopathy: A rebalanced hemostasis
    Achintya D. Singh, MD, MBBS, Simon R. Mucha, MD and Christina C. Lindenmeyer, MD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 523-533; DOI: https://doi.org/10.3949/ccjm.89a.21018

    Cirrhosis affects all 3 phases of coagulation, leading to a delicate new equilibrium, easily disturbed and tipped toward either bleeding or thrombosis by acute events such as infection, renal failure, and invasive procedures.

Pages